flanders.bio

& MEDVIA have merged and become Biovia.
This account is no longer active. Please follow us on LinkedIn:

[flanders.bio @flandersbio]

https://t.co/0b4PPcsmIb has merged with @MEDVIA_be
to become Biovia. This account will no longer be updated. Please follow us on LinkedIn. ➡️https://t.co/vDcRBnOshZ

[flanders.bio @flandersbio]

At the upcoming shareholders’ meeting, @biotalys will be appointing Toni Bucci as independent director to its Board of Directors.

👩🏽‍🔬 https://t.co/bmZxvLMqPG

[flanders.bio @flandersbio]

Augustine Therapeutics successfully completed its Series A financing round, raising a total of EUR 77.7 million. The proceeds will be used to advance Augustine’s lead candidate, AGT-100216.

🔗 https://t.co/GBi3bCJwJ2

[flanders.bio @flandersbio]

By reprogramming the metabolism of T cells, scientists at the @vib_ccb and their collaborators demonstrated a remarkable ability to boost the immune system's fight against cancer.

🦠 https://t.co/mT0Ja0Qh8J

[flanders.bio @flandersbio]

New research, led by researchers at the @VIBLifeSciences-@ugent Center for Plant Systems Biology, provides a comprehensive understanding of how #brassinosteroids influence development at the cellular level.

🌿 https://t.co/N6Po6L5LBu

[flanders.bio @flandersbio]

Field trials with one of @biotalys’ lead candidates for #BioFun6 highlight the increased potency of the new candidate against #Botrytis and #PowderyMildew in fruits and vegetables.

🍇 https://t.co/KUos2QorXF

[flanders.bio @flandersbio]

Positive interim results in @Agomab_’s ongoing #STENOVA Phase 2a clinical trial for the potential treatment of Fibrostenosing Crohn’s Disease (#FSCD)!

🔬 https://t.co/1xnenAgwG3

[flanders.bio @flandersbio]

4Tissue has completed a €1.5M funding round to advance its bioresorbable #hydrogel technology. The company is also excited to welcome Dr. Katleen Verleysen as independent chair of the board.

🚀https://t.co/XYjznNm2M0

[flanders.bio @flandersbio]

Big news for #RRP patients! @Precigen’s biologics license application (#BLA) for PRGN-2012, a groundbreaking AdenoVerse® #genetherapy, has been accepted by the FDA. With priority review granted, the FDA has set a target action date of Aug 27, 2025.

🫁 https://t.co/1xMbDp0MCu

[flanders.bio @flandersbio]

Prof. Stein Aerts and his team at https://t.co/AWYQvbqST5 and @CBD_VIB explored how genetic switches, controlling gene activity, define brain cell types across species. Their study was published in Science.

🔗 https://t.co/jz42k8YxKH

[flanders.bio @flandersbio]

Augustine Therapeutics has appointed Gerhard Koenig, PhD, as Chief Executive Officer.

🔗 https://t.co/YLSaIR6Zq6

[flanders.bio @flandersbio]

Allegro Biotech has been awarded the prestigious #CompanionAnimalsPrize at the #AnimalHealthEurope2025 Conference in London. 🏆

🔗 https://t.co/AUJ0Suo18W

[flanders.bio @flandersbio]

📆 Don’t miss Knowledge for Growth on 8 May, where we will unveil the name of our new, unified organization, provide an update on the structure and goals and commence with appropriate celebrations! 🍾

𝗠𝗼𝗿𝗲 𝗼𝗻 𝘁𝗵𝗲 𝗺𝗲𝗿𝗴𝗲𝗿 𝗵𝗲𝗿𝗲 👉 https://t.co/KlLlBkmhV9

[flanders.bio @flandersbio]

✅ Yesterday our members voted in favor of a merger with @MEDVIA_be — an overwhelming 98% approval from 124 present or represented effective members! This follows the 96% majority vote among MEDVIA’s members in January.

[flanders.bio @flandersbio]

⛙ Over the next few days and months, we will further finalize this powerful merger to officially create one, new organization. 🔥 With a united voice, we will represent the entire #biotech and #healthtech ecosystem on the regional, federal and European stage. How cool is that?

[flanders.bio @flandersbio]

🚨 Early bird registration for #KfG2025 closes 15 Feb 2025, 23:59 CEST!
Join our top life sciences event to connect, learn, and discover the future of #biotech, #pharma, #medtech & #healthtech 🌱
💸 Don’t miss the best rate — register now 👉 https://t.co/VgTxncAB4d
#lifesciences

[flanders.bio @flandersbio]

Researchers at @VIB_microbes and @CBD_VIB revealed the relationship between #ProteinAggregation and #BacterialDormancy, states during which bacteria are not susceptible to #antibiotics.

🧫 https://t.co/ba0D3iKYew

[flanders.bio @flandersbio]

New research by the team of Prof. Charlotte Scott (@VIBLifeSciences) reveals that a specific activation state of one of the immune cell types in our livers is required for tissue repair following injury.

🔗 https://t.co/pBKfxoszqs

[flanders.bio @flandersbio]

A strong #BiotechAct is a vital step towards unlocking the full potential of #biotechnology to support healthy citizens, robust economies, and a sustainable future.

Read more about this visionary approach below ⬇
https://t.co/eJBNWYahPy

[flanders.bio @flandersbio]

Including groundbreaking innovations in #humanhealth, #animalhealth, #agrifood, and #industrial biotechnologies, this ambitious initiative is designed to strengthen value chains, simplify regulatory pathways, and foster a thriving ecosystem for innovation. 🌾🏭💊

[flanders.bio @flandersbio]

🚀 EuropaBio’s vision for the #EUBiotechAct marks a transformative step for the entire #biotech sector.